Replies to post #419189 on Amarin Corp Plc (AMRN)

[couldbebetter]

I am not in disagreement. However, with regard to the potential of Vascepa for
other indications such as cancer...I would hope that Denner & AMRN management
would be working at getting a BP interested in using Vascepa as an adjunct drug
without having AMRN to pay for it. Right now I am more interested that Denner is
making the right moves behind the scenes rather than hyping the stock. Again,
my core belief is that the vast potential of Vascepa (or some derivative) can only
be unlocked with BP ownership. Denner should know that which would mean
ultimately he would sell AMRN to BP. My belief is that Europe is a $2 billion+
market for Vascepa if it were owned by BP. If only Denner could convince a
BP of that!